NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

AnphA.00984.a: 5-aminolevulinate synthase

Target Characteristics

from organism: Anaplasma phagocytophilum HZ
most recent status: cloned
center reference id: AnphA.00984.a
is community request: False
associated disease: Human granulocytic anaplasmosis
NIH risk group: 1
is select agent: False
NIH priority
pathogens category:
I

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

External Resources

Resource Reference ID
OrthoMCL: OG5_126783
PATRIC ID: fig|212042.8.peg.1335
RefSeq: YP_505769.1
UniProt: Q2GIN2

Enzyme & Pathway Information

Pathway Pathway ID EC Number
tetrapyrrole biosynthesis II (from glycine) PWY-5189 2.3.1.37
superpathway of bacteriochlorophyll a biosynthesis PWY-5529 2.3.1.37
superpathway of b heme biosynthesis from glycine PWY-5920 2.3.1.37
2-amino-3-hydroxycyclopent-2-enone biosynthesis PWY-7536 2.3.1.37

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MIDYEEVFRE RINGIKEEGR YREFTGFRRV PGRFPYAIEC QTERVVTLWC SNDYLGMSQH ESVLSAARNL NVNVGAGGTR NISGTTEEVI ELERSLADLH NKPAALAFVC GYVANQTSIS TILATIPDVV VFSDEKNHSS MIEGIRAGNR VKHIFRHNDV EHLESLLKAA GASPKIILFE SVYSMDGDIA PIKEICDLAS KYNAITYLDE VHAVGLYGAR GGGISEMEGL ADRISVIQGT LSKAFGVMGG YVAASKSLVD VIRSFAPGFI FTTAISPLIA ASARASVEHL KNSNIEREKH REVIAKVKSA LLQAGIEFLM TDTHIIPVII GDATICKQVS QALLRDHGIY IQSINYPTVP LGTERLRITP TPYHTDEMID HLVKGLQEVF SRFSVPAGRS YAYFEALGKL KESR

NT Sequence
ATGATAGATT ACGAGGAAGT GTTTCGTGAG AGAATCAATG GCATAAAAGA AGAAGGTAGA TACCGAGAGT TTACGGGGTT TCGTCGTGTT CCTGGTAGGT TTCCATATGC TATTGAGTGC CAAACAGAGC GGGTAGTTAC GCTATGGTGC AGTAATGATT ATCTAGGAAT GAGCCAGCAC GAAAGCGTGT TATCTGCTGC TAGGAACCTA AATGTTAATG TGGGTGCTGG GGGCACTAGA AATATTTCCG GTACTACTGA GGAAGTTATT GAGCTCGAAC GTTCTCTTGC AGATCTACAT AACAAACCTG CAGCATTGGC CTTTGTGTGT GGTTACGTTG CGAATCAGAC AAGTATAAGC ACTATTTTGG CCACAATTCC GGATGTTGTG GTTTTTTCAG ATGAGAAAAA TCACTCTTCC ATGATTGAGG GAATACGCGC TGGTAACAGA GTCAAACACA TCTTCAGACA TAATGATGTA GAACATTTGG AGAGTTTGCT AAAGGCCGCA GGGGCTAGTC CTAAGATTAT ACTCTTTGAG TCCGTATACT CTATGGATGG GGATATAGCT CCTATCAAGG AAATATGTGA CTTGGCCAGC AAGTACAATG CTATAACGTA TCTCGATGAG GTACACGCTG TAGGGTTATA TGGTGCTCGT GGGGGAGGCA TATCAGAGAT GGAAGGCCTT GCAGATAGGA TTTCCGTTAT ACAGGGCACC TTATCTAAGG CTTTTGGAGT TATGGGAGGC TATGTTGCGG CATCAAAGAG CCTTGTGGAT GTTATCAGGA GTTTTGCTCC TGGATTCATA TTTACTACGG CTATATCACC GTTGATAGCT GCGTCTGCTC GTGCAAGTGT TGAGCATTTA AAAAACAGTA ATATAGAACG AGAGAAGCAT AGGGAAGTTA TAGCCAAAGT GAAGAGTGCT TTGCTGCAGG CTGGTATTGA GTTTCTTATG ACGGACACTC ATATAATTCC TGTTATCATA GGGGATGCAA CGATATGCAA GCAAGTTTCA CAAGCTCTGT TGCGTGACCA TGGAATATAT ATTCAATCCA TTAATTACCC TACTGTGCCA TTGGGGACTG AGAGGCTCAG AATCACACCT ACCCCGTACC ATACTGATGA AATGATAGAT CACTTAGTCA AAGGGCTACA GGAAGTGTTT TCGAGGTTTT CGGTACCTGC GGGAAGGAGT TATGCATATT TTGAGGCATT AGGTAAGTTA AAAGAAAGTC GT

© 2019 Seattle Children's Research Institute. All rights reserved.